213
Views
2
CrossRef citations to date
0
Altmetric
Gynaecology

Are all antral follicles the same? Size of antral follicles as a key predictor for response to controlled ovarian stimulation

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all

References

  • Alson SSE, Bungum LJ, Giwercman A, Henic E. 2018. Anti-müllerian hormone levels are associated with live birth rates in ART, but the predictive ability of anti-Müllerian hormone is modest. European Journal of Obstetrics & Gynecology and Reproductive Biology 225:199–204.
  • Alviggi C, Conforti A, Esteves SC. 2015. Impact of mutations and polymorphisms of gonadotrophins and their receptors on the outcome of controlled ovarian stimulation. In: Ghumman S, editor. Principles and practice of controlled ovarian stimulation in ART. New Delhi: Springer. p. 147–56.
  • Alviggi C, Conforti A, Esteves SC, Vallone R, Venturella R, Staiano S, et al. 2018. Understanding ovarian hypo-response to exogenous gonadotropin in ovarian stimulation and its new proposed marker-The follicle to oocyte (FOI) index. Frontiers in Endocrinolog 9:589.
  • Alviggi C, Pettersson K, Longobardi S, Andersen C, Conforti A, De Rosa P, et al. 2013. A common polymorphic allele of the LH beta-subunit gene is associated with higher exogenous FSH consumption during controlled ovarian stimulation for assisted reproductive technology. Reproductive Biology and Endocrinology 11:51.
  • Biasoni V, Patriarca A, Dalmasso P, Bertagna A, Manieri C, Benedetto C, et al. 2011. Ovarian sensitivity index is strongly related to circulating AMH and may be used to predict ovarian response to exogenous gonadotropins in IVF. Reproductive Biology and Endocrinology 9:112.
  • Bosch E, Ezcurra D. 2011. Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients. Reproductive Biology and Endocrinology 9:82
  • Christianson MS, Shoham G, Tobler KJ, Zhao Y, Cordeiro CN, Leong M, et al. 2015. Measurement of antral follicle count in patients undergoing in vitro fertilization treatment: results of a worldwide web-based survey. Journal of Assisted Reproduction and Genetics 32:1435–1440.
  • Drakopoulos P, Santos-Ribeiro S, Bosch E, Garcia-Velasco J, Blockeel C, Romito A, et al. 2018. The effect of dose adjustments in a subsequent cycle of women with suboptimal response following conventional ovarian stimulation. Frontiers in Endocrinology 9:361.
  • Eppsteiner EE, Sparks AET, Liu D, Van Voorhis BJ. 2014. Change in oocyte yield in repeated in vitro fertilization cycles: effect of ovarian reserve. Fertility and Sterility 101:399–402.
  • Broekmans FJ. 2015. The suboptimal response to controlled ovarian stimulation: manageable or inevitable? Human Reproduction 30:2009–2010.
  • Fleming R, Seifer DB, Frattarelli JL, Ruman J. 2015. Assessing ovarian response: antral follicle count versus anti-Müllerian hormone. Reproductive Biomedicine Online 31:486–496.
  • Genro VK, Matte U, De Conto E, Cunha-Filho JS, Fanchin R. 2012. Frequent polymorphisms of FSH receptor do not influence antral follicle responsiveness to follicle-stimulating hormone administration as assessed by the Follicular Output RaTe (FORT). Journal of Assisted Reproduction and Genetics 29:657–663.
  • Hassan AMA, Kotb MMM, AwadAllah AMA, Shehata NAA, Wahba A. 2017. Follicular sensitivity index (FSI): a novel tool to predict clinical pregnancy rate in IVF/ICSI cycles. Journal of Assisted Reproduction and Genetics 34:1317–1324.
  • Hernández J, Rodríguez-Fuentes A, Puopolo M, Palumbo A. 2016. Follicular volume predicts oocyte maturity: a prospective cohort study using three-dimensional ultrasound and SonoAVC. Reproductive Sciences 23:1639–1643.
  • Huber M, Hadziosmanovic N, Berglund L, Holte J. 2013. Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone-agonist protocol: suggestions for a new principle to solve an old problem. Fertility and Sterility 100:1270–1276.
  • Jayaprakasan K, Deb S, Batcha M, Hopkisson J, Johnson I, Campbell B, et al. 2010. The cohort of antral follicles measuring 2-6 mm reflects the quantitative status of ovarian reserve as assessed by serum levels of anti-Müllerian hormone and response to controlled ovarian stimulation. Fertility and Sterility 94:1775–1781.
  • La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, et al. 2010. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Human Reproduction Update 16:113–130.
  • La Marca A, Sunkara SK. 2014. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Human Reproduction Update 20:124–140.
  • Lai Q, Chen C, Zhang Z, Zhang S, Yu Q, Yang P, et al. 2013. The significance of antral follicle size prior to stimulation in predicting ovarian response in a multiple dose GnRH antagonist protocol. International Journal of Clinical and Experimental Pathology 6:258–266.
  • Li HWR, Lee VCY, Ho PC, Ng EHY. 2014. Ovarian sensitivity index is a better measure of ovarian responsiveness to gonadotrophin stimulation than the number of oocytes during in-vitro fertilization treatment. Journal of Assisted Reproduction and Genetics 31:199–203.
  • Barreto Melo MA, Garrido N, Alvarez C, Bellver J, Meseguer M, Pellicer A, et al. 2009. Antral follicle count (AFC) can be used in the prediction of ovarian response but cannot predict the oocyte/embryo quality or the in vitro fertilization outcome in an egg donation program. Fertility and Sterility 91:148–156.
  • Mohiyiddeen L, Newman WG, McBurney H, Mulugeta B, Roberts SA, Nardo LG, et al. 2012. Follicle-stimulating hormone receptor gene polymorphisms are not associated with ovarian reserve markers. Fertility and Sterility 97:677–681.
  • Nelson SM. 2013. Biomarkers of ovarian response: current and future applications. Fertility and Sterility 99:963–969.
  • Nelson SM, Klein BM, Arce JC. 2015. Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials. Fertility and Sterility 103:923–930.
  • Perez Mayorga M, Gromoll J, Behre HM, Gassner C, Nieschlag E, Simoni M. 2000. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. Journal of Clinical Endocrinology and Metabolism. 85:3365–3369.
  • Pöhl M, Hohlagschwandtner M, Obruca A, Poschalko G, Weigert M, Feichtinger W, et al. 2000. Number and size of antral follicles as predictive factors in vitro fertilization and embryo transfer. Journal of Assisted Reproduction and Genetics 17:315–318.
  • Polyzos NP, Sunkara SK. 2015. Sub-optimal responders following controlled ovarian stimulation: an overlooked group? Human Reproduction 30:2005–2008.
  • Practice Committee of the American Society for Reproductive Medicine. 2015. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertility and Sterility 103:e9–e17.
  • Raju GAR, Chavan R, Deenadayal M, Gunasheela D, Gutgutia R, Haripriya G, et al. 2013. Luteinizing hormone and follicle stimulating hormone synergy: a review of role in controlled ovarian hyper-stimulation. Journal of Human Reproductive Sciences 6:227–234.,
  • Rombauts L, Lambalk CB, Schultze-Mosgau A, van Kuijk J, Verweij P, Gates D, et al. 2015. Intercycle variability of the ovarian response in patients undergoing repeated stimulation with corifollitropin alfa in a gonadotropin-releasing hormone antagonist protocol. Fertility and Sterility 104:884–890.
  • Sanverdi I, Ozkaya E, Kucur S, Bilen D, Eken M, Bilgic B, et al. 2018. Antral follicle diameter variance within each ovary may be a predictor for poor response in cases with normal ovarian reserve. Experimental and Clinical Endocrinology & Diabetes 126:521–527.
  • Sen A, Prizant H, Light A, Biswas A, Hayes E, Lee H-J, et al. 2014. Androgens regulate ovarian follicular development by increasing follicle stimulating hormone receptor and microRNA-125b expression. Proceedings of the National Academy of Sciences of the United States of America 111:3008–3013. ‐
  • Sighinolfi G, Grisendi V, La M. 2017. How to personalize ovarian stimulation in clinical practice. Journal of the Turkish German Gynecological Association 18:148–153.
  • Simoni M, Nieschlag E, Gromoll J. 2002. Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. Human Reproduction Update 8:413–421.
  • Weenen C, Laven JS, Von Bergh A, Cranfield M, Groome NP, Visser JA, et al. 2004. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Molecular Human Reproduction 10:77–83.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.